RASGRP2 gene variations associated with platelet dysfunction and bleeding

References

• Kawasaki H, Springett GM, Toki S, Canales JJ, Harlan P, Blumenstiel JP, Chen EJ, Bany IA, Mochizuki N, Ashbacher A, et al. A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia. Proc Natl Acad Sci USA 1998;95:13278–13283.
   PubMed Web of Science ®Google Scholar
• Crittenden JR, Bergmeier W, Zhang Y, Piffath CL, Liang Y, Wagner DD, Housman DE, Graybiel AM. CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat Med 2004;10:982–986. doi:10.1038/nm1098.
   PubMed Web of Science ®Google Scholar
• Stefanini L, Bergmeier W. CalDAG-GEFI and platelet activation. Platelets 2010;21:239–243. doi:10.3109/09537101003639931.
   PubMed Web of Science ®Google Scholar
• Ebinu JO, Bottorff DA, Chan EY, Stang SL, Dunn RJ, Stone JC. RasGRP, a Ras guanyl nucleotide- releasing protein with calcium- and diacylglycerol-binding motifs. Science 1998;280:1082–1086.
   PubMed Web of Science ®Google Scholar
• Stefanini L, Bergmeier W. RAP GTPases and platelet integrin signaling. Platelets 2018;1–7. doi:10.1080/09537104.2018.1476681.
   PubMed Web of Science ®Google Scholar
• Canault M, Ghalloussi D, Grosdidier C, Guinier M, Perret C, Chelghoum N, Germain M, Raslova H, Peiretti F, Morange PE, et al. Human CalDAG-GEFI gene (RASGRP2) mutation affects platelet function and causes severe bleeding. J Exp Med 2014;211:1349–1362. doi:10.1084/jem.20130477.
   PubMed Web of Science ®Google Scholar
• Lozano ML, Cook A, Bastida JM, Paul DS, Iruin G, Cid AR, Adan-Pedroso R, Ramon Gonzalez-Porras J, Hernandez-Rivas JM, Fletcher SJ, et al. Novel mutations in RASGRP2, which encodes CalDAG-GEFI, abrogate Rap1 activation, causing platelet dysfunction. Blood 2016;128:1282–1289. doi:10.1182/blood-2015-11-683102.
   PubMed Web of Science ®Google Scholar
• Sevivas T, Bastida JM, Paul DS, Caparros E, Palma-Barqueros V, Coucelo M, Marques D, Ferrer-Marin F, Gonzalez-Porras JR, Vicente V, et al. Identification of two novel mutations in RASGRP2 affecting platelet CalDAG-GEFI expression and function in patients with bleeding diathesis. Platelets 2018;29:192–195. doi:10.1080/09537104.2017.1336214.
   PubMed Web of Science ®Google Scholar
• Cook AA, Deng W, Ren J, Li R, Sondek J, Bergmeier W. Calcium-induced structural rearrangements release autoinhibition in the Rap-GEF CalDAG-GEFI. J Biol Chem 2018;293:8521–8529. doi:10.1074/jbc.RA118.002712.
   PubMed Web of Science ®Google Scholar
• Stefanini L, Bergmeier W. RAP1-GTPase signaling and platelet function. J Mol Med (Berl) 2016;94:13–19. doi:10.1007/s00109-015-1346-3.
   PubMed Web of Science ®Google Scholar
• Eto K, Murphy R, Kerrigan SW, Bertoni A, Stuhlmann H, Nakano T, Leavitt AD, Shattil SJ. Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling. Proc Natl Acad Sci U S A 2002;99:12819–12824. doi:10.1073/pnas.202380099.
   PubMed Web of Science ®Google Scholar
• Stefanini L, Lee RH, Paul DS, O’Shaughnessy EC, Ghalloussi D, Jones CI, Boulaftali Y, Poe KO, Piatt R, Kechele DO, et al. Functional redundancy between RAP1 isoforms in murine platelet production and function. Blood 2018;132:1951–1962. doi:10.1182/blood-2018-03-838714.
   PubMed Web of Science ®Google Scholar
• Bergmeier W, Stefanini L. Platelet signaling–blood’s great balancing act. Oncotarget 2015;6:19922–19923. doi:10.18632/oncotarget.5122.
   PubMedGoogle Scholar
• Stolla M, Stefanini L, Andre P, Ouellette TD, Reilly MP, McKenzie SE, Bergmeier W. CalDAG-GEFI deficiency protects mice in a novel model of Fcgamma RIIA-mediated thrombosis and thrombocytopenia. Blood 2011;118:1113–1120. doi:10.1182/blood-2011-03-342352.
   PubMed Web of Science ®Google Scholar
• Bergmeier W, Goerge T, Wang HW, Crittenden JR, Baldwin AC, Cifuni SM, Housman DE, Graybiel AM, Wagner DD. Mice lacking the signaling molecule CalDAG-GEFI represent a model for leukocyte adhesion deficiency type III. J Clin Invest 2007;117:1699–1707. doi:10.1172/JCI30575.
   PubMed Web of Science ®Google Scholar
• Piatt R, Paul DS, Lee RH, McKenzie SE, Parise LV, Cowley DO, Cooley BC, Bergmeier W. Mice expressing low levels of CalDAG-GEFI exhibit markedly impaired platelet activation with minor impact on hemostasis. Arterioscler Thromb Vasc Biol 2016;36:1838–1846. doi:10.1161/ATVBAHA.116.307874.
   PubMed Web of Science ®Google Scholar
• Kato H, Nakazawa Y, Kurokawa Y, Kashiwagi H, Morikawa Y, Morita D, Banno F, Honda S, Kanakura Y, Tomiyama Y. Human CalDAG-GEFI deficiency increases bleeding and delays alphaIIbbeta3 activation. Blood 2016;128:2729–2733. doi:10.1182/blood-2016-03-704825.
   PubMed Web of Science ®Google Scholar
• Bermejo E, Alberto MF, Paul DS, Cook AA, Nurden P, Sanchez Luceros A, Nurden AT, Bergmeier W. Marked bleeding diathesis in patients with platelet dysfunction due to a novel mutation in RASGRP2, encoding CalDAG-GEFI (P.Gly305asp). Platelets 2018;29:84–86. doi:10.1080/09537104.2017.1332759.
   PubMed Web of Science ®Google Scholar
• Westbury SK, Canault M, Greene D, Bermejo E, Hanlon K, Lambert MP, Millar CM, Nurden P, Obaji SG, Revel-Vilk S, et al. Expanded repertoire of RASGRP2 variants responsible for platelet dysfunction and severe bleeding. Blood 2017;130:1026–1030. doi:10.1182/blood-2017-03-776773.
   PubMed Web of Science ®Google Scholar
• Desai A, Bergmeier W, Canault M, Alessi MC, Paul DS, Nurden P, Pillois X, Jy W, Ahn YS, Nurden AT. Phenotype analysis and clinical management in a large family with a novel truncating mutation in RASGRP2, the CalDAG-GEFI encoding gene. Res Pract Thromb Haemost 2017;1:128–133. doi:10.1002/rth2.12019.
   PubMed Web of Science ®Google Scholar
• Lyu SJ, Ren WR, Zhu HL, Liu T. The clinical characteristics and molecular pathogenesis of a variant Glanzmann’s thrombasthenia-like pedigree. Zhonghua Xue Ye Xue Za Zhi 2018;39:807–811. doi:10.3760/cma.j.issn.0253-2727.2018.10.004.
   PubMedGoogle Scholar
• Bastida JM, Lozano ML, Benito R, Janusz K, Palma-Barqueros V, Del Rey M, Hernandez-Sanchez JM, Riesco S, Bermejo N, Gonzalez-Garcia H, et al. Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders. Haematologica 2018;103:148–162. doi:10.3324/haematol.2017.171132.
   PubMed Web of Science ®Google Scholar
• Bastida JMBR, Lozano ML, Marín A, Janusz K, Martín-Izquierdo M, Hernández-Sánchez J, Palma-Barqueros V, Hernández-Rivas JM, Rivera J, González-Porras JR. Molecular diagnosis of inherited coagulation and bleeding disorders. Seminars in Thrombosis and Hemostasis 2019. ( Accepted). doi:10.1016/j.ajog.2018.12.024.
   Google Scholar